ALERT! Warning: your browser isn't supported. Please install a modern one, like Firefox, Opera, Safari, Chrome or the latest Internet Explorer. Thank you!
Specifications Manual for Joint Commission National Quality Measures (v2016B1)
Home » ARB Prescribed for LVSD in the Outpatient Setting

Release Notes:
Data Element
Version 2016B1

Data Element Name: ARB Prescribed for LVSD in the Outpatient Setting
Collected For: ACHFOP-02,
Definition:Documentation that an angiotensin receptor blocker (ARB) was prescribed for LVSD in the outpatient setting. ARBs widen or dilate blood vessels, lowering blood pressure and making it easier for the heart to pump blood. They also inhibit the adverse effects of neurohormonal activation on the heart. These effects help reduce the risk of adverse outcomes such as death or hospitalization.
Suggested Data Collection Question:Was an angiotensin receptor blocker (ARB) prescribed for LVSD in the outpatient setting?
Format:
Length:1
Type:Alphanumeric
Occurs:1
Allowable Values:

Y (Yes) ARB was prescribed for LVSD in the outpatient setting, or the patient is currently on an ARB.

N (No) ARB was not prescribed for LVSD in the outpatient setting, or unable to determine from medical record documentation.
Notes for Abstraction:
  • All medications prescribed in the outpatient setting should be reviewed and taken into account by the abstractor.
  • If the patient is currently on an ARB, answer “Yes”.
Suggested Data Sources:

  • Discharge summary
  • Discharge instruction sheet
  • Outpatient medical record
Additional Notes:
Guidelines for Abstraction:
Inclusion Exclusion
Refer to Appendix C Table 1.7 for a comphrensive list of ARB's. None

ARB Prescribed for LVSD in the Outpatient Setting
Specifications Manual for Joint Commission National Quality Measures (v2016B1)
Discharges 01-01-17 (1Q17) through 06-30-17 (2Q17)
^